| 000 | 01656 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514164633.0 | ||
| 264 | 0 | _c20040615 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0172-6390 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNoritomi, Tomoaki | |
| 245 | 0 | 0 |
_aRefractory acute rejection in a living related liver transplantation. _h[electronic resource] |
| 260 |
_bHepato-gastroenterology _c |
||
| 300 |
_a2192-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Rejection _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xsurgery |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLiver _ximmunology |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xsurgery |
| 650 | 0 | 4 |
_aLiver Transplantation _ximmunology |
| 650 | 0 | 4 | _aLiving Donors |
| 650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuromonab-CD3 _xadministration & dosage |
| 650 | 0 | 4 |
_aPostoperative Complications _xdrug therapy |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 700 | 1 | _aSugawara, Yasuhiko | |
| 700 | 1 | _aKaneko, Junichi | |
| 700 | 1 | _aMatsui, Yuichi | |
| 700 | 1 | _aMakuuchi, Masatoshi | |
| 773 | 0 |
_tHepato-gastroenterology _gvol. 50 _gno. 54 _gp. 2192-3 |
|
| 999 |
_c14427195 _d14427195 |
||